Featured Posters & Presentations
Zynteglo
Safety and efficacy of LentiGlobin gene therapy for transfusion-dependent β-thalassemia (TDT) in patients with non-β0/β0 genotypes: interim results from the HGB-204 (Northstar) and HGB-207 (Northstar-2) trials.
Authors: Locatelli F.